Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population - PubMed (original) (raw)
Multicenter Study
doi: 10.1136/ard.2005.048181. Epub 2006 Feb 7.
Y Allanore, A Kahan, O Meyer, L Mouthon, L Guillevin, C Pierlot, E Glikmans, T Bardin, C Boileau, F Cornélis, P Dieudé
Affiliations
- PMID: 16464986
- PMCID: PMC1798267
- DOI: 10.1136/ard.2005.048181
Multicenter Study
Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population
J Wipff et al. Ann Rheum Dis. 2006 Sep.
Abstract
The minor allele of the R620W missense single-nucleotide polymorphism (SNP; rs2476601) in the PTPN22 (protein tyrosine phosphatase non-receptor 22) gene has been reported to be associated with multiple autoimmune diseases, including type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, autoimmune thyroiditis and vitiligo. Systemic sclerosis (SSc) is a connective tissue disease with some autoimmune abnormalities. The aim of our study was to test for association of the PTPN22*620W allele with SSc in a French Caucasian cohort with a case-control study of 121 patients with SSc and 103 controls. All patients and controls were genotyped for the PTPN22*R620W SNP. No association was found between the PTPN22*620W allele and SSc (7% v 9.2%, p = 0.39). The frequency of genotypes carrying at least one 620W allele was similar in both groups (13% v 17%, p = 0.38). The PTPN22*620W allele was also not associated with autoantibody patterns. Thus, the PTPN22*R620W polymorphism cannot be regarded as a genetic susceptibility factor for SSc in the French Caucasian population.
Conflict of interest statement
Competing interests: None declared.
Similar articles
- Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
Gourh P, Tan FK, Assassi S, Ahn CW, McNearney TA, Fischbach M, Arnett FC, Mayes MD. Gourh P, et al. Arthritis Rheum. 2006 Dec;54(12):3945-53. doi: 10.1002/art.22196. Arthritis Rheum. 2006. PMID: 17133608 - Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
van Oene M, Wintle RF, Liu X, Yazdanpanah M, Gu X, Newman B, Kwan A, Johnson B, Owen J, Greer W, Mosher D, Maksymowych W, Keystone E, Rubin LA, Amos CI, Siminovitch KA. van Oene M, et al. Arthritis Rheum. 2005 Jul;52(7):1993-8. doi: 10.1002/art.21123. Arthritis Rheum. 2005. PMID: 15986374 - The PTPN22 620W allele is a risk factor for Wegener's granulomatosis.
Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, Gross WL, Epplen JT. Jagiello P, et al. Arthritis Rheum. 2005 Dec;52(12):4039-43. doi: 10.1002/art.21487. Arthritis Rheum. 2005. PMID: 16320352 - Protein tyrosine phosphatase PTPN22 in human autoimmunity.
Vang T, Miletic AV, Bottini N, Mustelin T. Vang T, et al. Autoimmunity. 2007 Sep;40(6):453-61. doi: 10.1080/08916930701464897. Autoimmunity. 2007. PMID: 17729039 Review. - The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB. Lee YH, et al. Rheumatology (Oxford). 2007 Jan;46(1):49-56. doi: 10.1093/rheumatology/kel170. Epub 2006 Jun 7. Rheumatology (Oxford). 2007. PMID: 16760194 Review.
Cited by
- The Immunogenetics of Systemic Sclerosis.
Ünlü B, Türsen Ü, Rajabi Z, Jabalameli N, Rajabi F. Ünlü B, et al. Adv Exp Med Biol. 2022;1367:259-298. doi: 10.1007/978-3-030-92616-8_10. Adv Exp Med Biol. 2022. PMID: 35286699 - Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.
Yang C, Tang S, Zhu D, Ding Y, Qiao J. Yang C, et al. Front Med (Lausanne). 2020 Nov 19;7:587773. doi: 10.3389/fmed.2020.587773. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33330547 Free PMC article. Review. - Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
Tóth KF, Ádám D, Bíró T, Oláh A. Tóth KF, et al. Molecules. 2019 Mar 6;24(5):918. doi: 10.3390/molecules24050918. Molecules. 2019. PMID: 30845666 Free PMC article. Review. - Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.
Tochimoto A, Kawaguchi Y, Yamanaka H. Tochimoto A, et al. Clin Med Insights Circ Respir Pulm Med. 2016 Mar 13;9(Suppl 1):135-40. doi: 10.4137/CCRPM.S23312. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2016. PMID: 26997879 Free PMC article. Review. - Pathogenesis of Systemic Sclerosis.
Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pattanaik D, et al. Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. Front Immunol. 2015. PMID: 26106387 Free PMC article. Review.
References
- Mustelin T, Abraham R T, Rudd CE Alonso A, Merlo J J. Protein tyrosine phosphorylation in T cell signaling. Front Biosci 20027d918–d969. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical